Biofidelity's mission is to enable the early detection of disease and to improve patient outcomes through the implementation of simple yet ultra-high sensitivity diagnostic assays based on our proprietary biochemistry.
We have developed a novel molecular assay enabling the multiplexed detection of genetic mutations at extremely high sensitivity (<0.1% allele fraction) from tissue or blood samples, without the need for DNA sequencing.
Using standard laboratory instrumentation, our assays are simple, fast, scalable and low-cost, enabling rapid implementation and broad adoption. The simplicity of this technology makes it particularly suited to routine testing applications, including patient monitoring for disease recurrence and developed resistance to therapy, and to early detection of disease.
Location: United Kingdom, England, Cambridge
Employees: 11-50
Total raised: $59M
Founded date: 2019
Investors 3
Date | Name | Website |
29.03.2022 | Octopus Ve... | octopusven... |
- | Oxford Inv... | oxfordinve... |
20.11.2022 | Perscitus ... | perscitusl... |
Funding Rounds 3
Date | Series | Amount | Investors |
04.04.2024 | - | $24M | Octopus Ve... |
01.02.2022 | Series A | $23M | - |
20.08.2020 | Series A | $12M | - |
Mentions in press and media 11
Date | Title | Description | Source |
06.04.2024 | Biofidelity Secures €22M in Funding: A Game-Changer in Genom... | Cambridge-based Biofidelity, a genomic technology company, has just locked in a hefty €22M in fundin... | parsers.vc... |
04.04.2024 | UK’s Biofidelity secures €22M from Octopus Ventures, others:... | Read this article in: Cambridge-based Biofidelity, a commercial-stage genomic technology company, an... | siliconcan... |
03.04.2024 | Biofidelity Raises $24M in Funding | Biofidelity, a Cambridge, UK- and Morrisville, NC-based genomic technology company, raised $24M in f... | finsmes.co... |
01.02.2022 | Biofidelity Raises $23M in Series A+ Financing | Biofidelity, a Cambridge UK-based cancer diagnostic company, raised $23M in Series A+ funding. The r... | finsmes.co... |
28.07.2021 | Biofidelity opens US headquarters and new cancer diagnostic ... | CAMBRIDGE, United Kingdom., July 28, 2021 (GLOBE NEWSWIRE) -- Biofidelity Ltd, the cancer diagnostic... | marketscre... |
07.04.2021 | Biofidelity granted key patent in US for breakthrough cancer... | CAMBRIDGE, United Kingdom, April 07, 2021 (GLOBE NEWSWIRE) -- Biofidelity Ltd, the cancer diagnostic... | marketscre... |
21.08.2020 | Biofidelity raises $12m in Series A financing to accelerate ... | Biofidelity Ltd, a Cambridge cancer diagnostics company, today announces the successful completion o... | cambridgen... |
21.08.2020 | Biofidelity raises $12m in Series A financing to accelerate ... | Biofidelity raises $12m in Series A financing to accelerate launch of disruptive cancer diagnostic t... | cambridgen... |
20.08.2020 | UK Cancer Diagnostics Startup Biofidelity Raises $12M | What You Should Know: – UK-based Biofidelity raises $12 million in Series A funding to accelerate th... | hitconsult... |
- | Biofidelity | “Unleashing the potential of genomics to transform the world we live in through transformational tec... | fastfounde... |
Show more